The trajectory of Viagra presents a complex case for observers in the medicinal sector. While initially a blockbuster success, creating huge profits, the patent lapse and the subsequent arrival of off-brand alternatives have significantly changed revenue. This presents questions about the ongoing profitability of similar therapeutic projects and… Read More